期刊文献+

PHOX2B蛋白、MYCN基因与外周神经母细胞性肿瘤临床病理特征及预后的关系

Relationship between PHOX2B protein and MCYN gene with clinicopathological features and prognosis of peripheral neuroblastic tumors
下载PDF
导出
摘要 目的探讨同源异型盒2B(PHOX2B)蛋白和N-MYC致癌基因(MYCN基因)状态与外周神经母细胞性肿瘤(pNT)临床病理特征和预后的关系。方法采用免疫组织化学染色化法检测41例pNT患儿组织中PHOX2B蛋白的表达,荧光原位杂交技术检测MYCN基因表达状态,并使用连续校正χ2检验和Kaplan-Meier法分析两者与临床病理特征及预后的关系。结果免疫组织化学染色显示PHOX2B蛋白主要定位于细胞核内,在pNT组织中阳性表达率为82.9%,其表达水平与pNT发病年龄、分化程度及预后有关(P<0.05),PHOX2B蛋白表达强度与MYCN基因状态无关(P>0.05)。MYCN基因扩增患儿生存期短于未扩增患儿(P<0.05)。结论PHOX2B蛋白对pNT具有诊断意义,可以作为pNT可靠的诊断标志物;MYCN基因状态与患儿生存期有关,可以帮助判断pNT患儿预后情况。 Objective To investigate the relationship between the paired like homeobox 2B(PHOX2B)protein and N-MYC oncogene(MYCN gene)status with the clinicopathological features and prognosis of peripheral neuroblastic tumors(pNT).Methods The PHOX2B protein expression in pNT tissues of 41 children cases of pNT was detected by immunohistochemical staining,the MYCN gene expression status was detected by fluorescence in situ hybridization technique,and their relationship with clinicopathological features and prognosis was analyzed by continuous correction chi-square test and Kaplan-Meier method.Results The immunohistochemical staining showed that PHOX2B protein was mainly localized in the cell nucleus,and the positive expression rate in pNT tissue was 82.9%.Its expression level was related to the onset age,differentiation degree and prognosis of pNT(P<0.05),and the intensity of PHOX2B protein expression was not related to the MYCN gene status(P>0.05).The survival stage in the children patients with MYCN gene amplification was shorter than that in the children patients with no MYCN gene amplification(P<0.05).Conclusion PHOX2B protein has the diagnostic significance for pNT and could be used as a reliable diagnostic marker for pNT;MYCN gene status is related to the survival period in the children patients,which can help to judge the prognosis of pNT children patients.
作者 李静羽 高吉照 LI Jingyu;GAO Jizhao(Department of Pathology,Affiliated Xuzhou Children’s Hospital,Xuzhou Medical University,Xuzhou,Jiangsu 221000,China;Department of Pediatrics,Affiliated Hospital of Xuzhou Medical University,Xuzhou,Jiangsu 221000,China)
出处 《重庆医学》 CAS 2024年第19期2997-3001,共5页 Chongqing Medical Journal
关键词 外周神经母细胞性肿瘤 同源异型盒2B蛋白 N-MYC致癌基因 预后 peripheral neuroblastic tumors paired like homeobox 2B protein N-MYC oncogene prognosis
  • 相关文献

参考文献4

二级参考文献28

  • 1胡惠丽,何乐健.神经母细胞瘤MYCN基因扩增和CD44的表达[J].中华病理学杂志,2004,33(4):332-336. 被引量:8
  • 2Smith MA,Seibel NL,Altekruse SF,et al. Outcomes for childrenand adolescents with cancer : challenges for the twenty-first century[J]. J Clin Oncol,2010,28(15) :2625-2634.
  • 3Maris JM. Recent advances in neuroblastoma[ J]. N Engl J Med,2010, 362(23);2202-2211.
  • 4Peuchmaur M,d, Amore ES, Joshi VV, et al. Revision of theInternational Neuroblastoma Pathology Classification: confirmationof favorable and unfavorable prognostic subsets inganglioneuroblastoma, nodular[ J ] . Cancer, 2003 ,98 (10) : 2274-2281.
  • 5Conte M,Parodi S, De Bemardi B, et al. Neuroblastoma inadolescents: the Italian experience [ J]. Cancer,2006,106 (6):1409-1417.
  • 6Moroz V,Machin D,Faldum A,et al. Changes over three decadesin outcome and the prognostic influence of age-at>diagnosis inyoung patients with neuroblastoma : a report from the InternationalNeuroblastoma Risk Group Project [ J ]. Eur J Cancer, 2011,47(4):561-571.
  • 7Seeger RC,Brodeur GM,Sather H,et al. Association of multiplecopies of the N-myc oncogene with rapid progression ofneuroblastomas[J]. N Engl J Med,1985 ,313( 18) :1111-1116.
  • 8Riley RD,Heney D,Jones DR, et al A systematic review ofmolecular and biological tumor maricers in neuroblastoma [ J ]. ClinCancer Res,2004,10( 1 Pt 1 ) :4-12.
  • 9Layfield U, Willmore-Payne C,Shimada H, et aL Assessment ofNMYC amplification: a comparison of FISH, quantitative PCRmonoplexing and traditional blotting methods used with fonnalin-fixed,paraffin-embedded neuroblastomas [ J ] . Anal Quant CytolHistol,2005,27(1) :5-14.
  • 10Ambros PF,Ambros IM,Brodeur GM,et al. Internationalconsensus for neuroblastoma molecular diagnostics : report from theInternational Neuroblastoma Risk Group ( INRG ) BiologyCommittee[ J]. Br J Cancer,2009,100(9) :1471-1482.

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部